하나제약

293480KOSPI

52.0 / 100

Reference Date: 2026-10-23

Financial Score22.5 / 40

News Sentiment12.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Slightly down 1.3% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Hana Pharmaceutical specializes in the production and sale of specialty pharmaceuticals, with a strong presence in analgesics and anesthetics. The company offers a wide range of health insurance-listed drugs and operates manufacturing plants in Hwaseong, Gyeonggi, along with an R&D center in Pangyo.

Number of Employees

706people

Average Salary

53.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

16.37Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

0.47Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

2.82Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

12.95Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲3.3% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼2.2% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 6.1% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 8,300Won52-week high 11,95052-week low 8,160

1-month return3.0Point

1m -1.31% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral[기재정정]신규시설투자등2026-10-16